Evaluation of a Minimally Invasive Cell Sampling Device Coupled with Assessment of Trefoil Factor 3 Expression for Diagnosing Barrett's Esophagus: A Multi-Center Case–Control Study

PLoS Medicine

Volumn 12, Issue 1, 2015, Pages 1-19

  Ross Innes, Caryn S ^a   Debiram Beecham, Irene ^a   O'Donovan, Maria ^b   Walker, Elaine ^a   Varghese, Sibu ^a   Lao Sirieix, Pierre ^a   Lovat, Laurence ^c   Griffin, Michael ^d   Ragunath, Krish ^e   Haidry, Rehan ^c   Sami, Sarmed S ^e   Kaye, Philip ^e   Novelli, Marco ^c   Disep, Babett ^d   Ostler, Richard ^f   Aigret, Benoit ^f   North, Bernard V ^f   Bhandari, Pradeep ^g   Haycock, Adam ^h   Morris, Danielle ⁱ   Attwood, Stephen ^j,k   Dhar, Anjan ^j,l   Rees, Colin ^j,m   Rutter, Matthew D D ^j,n   Sasieni, Peter D ^f   Fitzgerald, Rebecca C ^a   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d ROYAL VICTORIA INFIRMARY   (United Kingdom)

^e QUEEN S MEDICAL CENTRE   (United Kingdom)

^f Cancer Prevention Trials Unit   (United Kingdom)

^g QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^h ST MARK S HOSPITAL   (United Kingdom)

ⁱ MOUNT VERNON CANCER CENTRE   (United Kingdom)

^j Northern Region Endoscopy Group   (United Kingdom)

^k NORTH TYNESIDE GENERAL HOSPITAL   (United Kingdom)

^l Department of Occupational Health and Wellbeing   (United Kingdom)

^m CITY HOSPITALS SUNDERLAND NHS FOUNDATION TRUST   (United Kingdom)

ⁿ NORTH TEES AND HARTLEPOOL NHS FOUNDATION TRUST   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INTESTINAL TREFOIL FACTOR; PROTEIN P53; BIOLOGICAL MARKER; PEPTIDE; TFF3 PROTEIN, HUMAN;

ABRASION; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; BIOPSY; CASE CONTROL STUDY; CONTROLLED STUDY; CYTOSPONGE; DIGESTIVE DIAGNOSTIC DEVICE; DYSPEPSIA; DYSPLASIA; ENDOSCOPY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; PROTEIN EXPRESSION; REFLUX ESOPHAGITIS; VISUAL ANALOG SCALE; CLINICAL TRIAL; DEVICES; DIGESTIVE TRACT ENDOSCOPY; METABOLISM; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

AGED; BARRETT ESOPHAGUS; BIOMARKERS; CASE-CONTROL STUDIES; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES; SENSITIVITY AND SPECIFICITY;

EID: 84923834899     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001780     Document Type: Article

References (38)

1. Dent J, El-Serag HB, Wallander MA, Johansson S, (2005) Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 54: 710–717. 15831922
2. Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, et al. (2012) Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 143: 1179–1187. doi: 10.1053/j.gastro.2012.08.002 22885331
3. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, et al. (2005) Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 129: 1825–1831. 16344051
4. Zagari RM, Fuccio L, Wallander MA, Johansson S, Fiocca R, et al. (2008) Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Gut 57: 1354–1359. doi: 10.1136/gut.2007.145177 18424568
5. Gerson LB, Shetler K, Triadafilopoulos G, (2002) Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 123: 461–467. 12145799
6. Rex DK, Cummings OW, Shaw M, Cumings MD, Wong RKH, et al. (2003) Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 125: 1670–1677. 14724819
7. Ward EM, Wolfsen HC, Achem SR, Loeb DS, Krishna M, et al. (2006) Barrett's esophagus is common in older men and women undergoing screening colonoscopy regardless of reflux symptoms. Am J Gastroenterol 101: 12–17. 16405528
8. Lao-Sirieix P, Fitzgerald RC, (2012) Screening for oesophageal cancer. Nat Rev Clin Oncol 9: 278–287. doi: 10.1038/nrclinonc.2012.35 22430857
9. Desai TK, Krishnan K, Samala N, Singh J, Cluley J, et al. (2012) The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis. Gut 61: 970–976. doi: 10.1136/gutjnl-2011-300730 21997553
10. Hvid-Jensen F, Pedersen L, Drewes AM, Sorensen HT, Funch-Jensen P, (2011) Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 365: 1375–1383. doi: 10.1056/NEJMoa1103042 21995385
11. Zehetner J, DeMeester SR, Hagen JA, Ayazi S, Augustin F, et al. (2011) Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma. J Thorac Cardiovasc Surg 141: 39–47. doi: 10.1016/j.jtcvs.2010.08.058 21055772
12. Spechler SJ, (2013) Barrett esophagus and risk of esophageal cancer: a clinical review. JAMA 310: 627–636. doi: 10.1001/jama.2013.226450 23942681
13. Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, et al. (2014) British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut 63: 7–42. doi: 10.1136/gutjnl-2013-305372 24165758
14. Sharma P, McQuaid K, Dent J, Fennerty MB, Sampliner R, et al. (2004) A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 127: 310–330. 15236196
15. Corley DA, Mehtani K, Quesenberry C, Zhao W, de Boer J, et al. (2013) Impact of endoscopic surveillance on mortality From Barrett's esophagus–associated esophageal adenocarcinomas. Gastroenterology 145: 312–319. doi: 10.1053/j.gastro.2013.05.004 23673354
16. Bhat SK, McManus DT, Coleman HG, Johnston BT, Cardwell CR, et al. (2014) Oesophageal adenocarcinoma and prior diagnosis of Barrett's oesophagus: a population-based study. Gut 64: 20–25. doi: 10.1136/gutjnl-2013-305506 24700439
17. Phoa KN, van Vilsteren FG, Weusten BL, Bisschops R, Schoon EJ, et al. (2014) Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA 311: 1209–1217. doi: 10.1001/jama.2014.2511 24668102
18. Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, et al. (2009) Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 360: 2277–2288. doi: 10.1056/NEJMoa0808145 19474425
19. Haidry RJ, Dunn JM, Butt MA, Burnell MG, Gupta A, et al. (2013) Radiofrequency ablation and endoscopic mucosal resection for dysplastic Barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry. Gastroenterology 145: 87–95. doi: 10.1053/j.gastro.2013.03.045 23542069
20. Kadri SR, Lao-Sirieix P, O'Donovan M, Debiram I, Das M, et al. (2010) Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study. BMJ 341: c4372. doi: 10.1136/bmj.c4372 20833740
21. Lao-Sirieix P, Boussioutas A, Kadri SR, O'Donovan M, Debiram I, et al. (2009) Non-endoscopic screening biomarkers for Barrett's oesophagus: from microarray analysis to the clinic. Gut 58: 1451–1459. doi: 10.1136/gut.2009.180281 19651633
22. Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, et al. (1993) An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 105: 40–50. 8514061
23. Armitage P, (1955) Tests for linear trends in proportions and frequencies. Biometrics 11: 375–386.
24. Clopper C, Pearson ES, (1934) The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 26: 404–413.
25. Weaver JMJ, Ross-Innes C, Shannon N, Lynch AG, Forshew T, et al. (2014) Ordering of mutations in preinvasive disease stages of oesophageal carcinogenesis. Nat Genet 46: 837–843. doi: 10.1038/ng.3013 24952744
26. Wani S, Falk G, Hall M, Gaddam S, Wang A, et al. (2011) Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. Clin Gastroenterol Hepatol 9: 220–227. doi: 10.1016/j.cgh.2010.11.008 21115133
27. Weston AP, Sharma P, Mathur S, Banerjee S, Jafri AK, et al. (2004) Risk stratification of Barrett's esophagus: updated prospective multivariate analysis. Am J Gastroenterol 99: 1657–1666. 15330898
28. Pohl H, Arash H, Ell C, Manner H, May A, et al. (2014) Length of Barrett's esophagus and cancer risk—implications from a population based study [abstract]. Digestive Disease Week 2014; 3–6 May 2014; Chicago, Illinois, US. Gastroenterology 146: S-122. doi: 10.1053/j.gastro.2014.04.029 25284828
29. Whiting JL, Sigurdsson A, Rowlands DC, Hallissey MT, Fielding JW, (2002) The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 50: 378–381. 11839718
30. Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, et al. (2014) Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 370: 1287–1297. doi: 10.1056/NEJMoa1311194 24645800
31. Whitlock EP, Vesco KK, Eder M, Lin JS, Senger CA, et al. (2011) Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 155: 687–697. doi: 10.7326/0003-4819-155-10-201111150-00376 22006930
32. Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ, (2011) American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology 140: 1084–1091. doi: 10.1053/j.gastro.2011.01.030 21376940
33. Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ, (2011) American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology 140: e18–52. doi: 10.1053/j.gastro.2011.01.031 21376939
34. Benaglia T, Sharples LD, Fitzgerald RC, Lyratzopoulos G, (2013) Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus. Gastroenterology 144: 62–73.e66. doi: 10.1053/j.gastro.2012.09.060 23041329
35. Thrift AP, Kendall BJ, Pandeya N, Vaughan TL, Whiteman DC, et al. (2012) A clinical risk prediction model for Barrett esophagus. Cancer Prev Res (Phila) 5: 1115–1123. 22787114
36. Liu X, Wong A, Kadri SR, Corovic A, O'Donovan M, et al. (2014) Gastro-esophageal reflux disease symptoms and demographic factors as a pre-screening tool for Barrett's esophagus. PLoS ONE 9: e94163. doi: 10.1371/journal.pone.0094163 24736597
37. Steele RJC, McClements PL, Libby G, Black R, Morton C, et al. (2009) Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut 58: 530–535. doi: 10.1136/gut.2008.162883 19036949
38. Kavanagh AM, Giles GG, Mitchell H, Cawson JN, (2000) The sensitivity, specificity, and positive predictive value of screening mammography and symptomatic status. J Med Screen 7: 105–110. 11002452